Your browser doesn't support javascript.
loading
Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Suto, Takeshi; Ishiguro, Megumi; Hamada, Chikuma; Kunieda, Katsuyuki; Masuko, Hiroyuki; Kondo, Ken; Ishida, Hideyuki; Nishimura, Genichi; Sasaki, Kazuaki; Morita, Takayuki; Hazama, Shoichi; Maeda, Koutarou; Mishima, Hideyuki; Ike, Hideyuki; Sadahiro, Sotaro; Sugihara, Kenichi; Okajima, Masazumi; Saji, Shigetoyo; Sakamoto, Junichi; Tomita, Naohiro.
Afiliação
  • Suto T; Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, 1800 Aoyagi, Yamagata-shi, Yamagata, 990-2214, Japan.
  • Ishiguro M; Department of Translational Oncology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Hamada C; Graduate School of Engineering, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo, 125-8585, Japan.
  • Kunieda K; Department of Surgery, Gifu Prefectural General Medical Center, 4-6-1 Noishiki, Gifu-shi, Gifu, 500-8717, Japan.
  • Masuko H; Department of Surgery, Nikko Memorial Hospital, 1-5-13 Shintomi-cho, Muroran-shi, Hokkaido, 051-8501, Japan.
  • Kondo K; Department of Surgery, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya-shi, Aichi, 460-0001, Japan.
  • Ishida H; Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe-shi, Saitama, 350-8550, Japan.
  • Nishimura G; Department of Surgery, Kanazawa Red Cross Hospital, 2-251 Mimma, Kanazawa-shi, Ishikawa, 921-8162, Japan.
  • Sasaki K; Department of Surgery, Otaru Ekisaikai Hospital, 1-10-17 Ironai, Otaru-shi, Hokkaido, 047-0031, Japan.
  • Morita T; Department of Surgery, Aomori Prefectural Central Hospital, 2-1-1 Higashitsukurimichi, Aomori-shi, Aomori, 030-8553, Japan.
  • Hazama S; Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube-shi, Yamaguchi, 755-8505, Japan.
  • Maeda K; Department of Lower Gastrointestinal Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake-shi, Aichi, 470-1192, Japan.
  • Mishima H; Cancer Center, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan.
  • Ike H; Department of Surgery, Saiseikai Yokohama Southern Hospital, 3-2-10 Konandai, Konan-ku, Yokohama-shi, Kanagawa, 234-8503, Japan.
  • Sadahiro S; Department of Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara-shi, Kanagawa, 259-1193, Japan.
  • Sugihara K; Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Okajima M; The Second Department of Surgery, Hiroshima University School of Medicine, 7-33 Motomachi, Naka-ku, Hiroshima-shi, Hiroshima, 730-8518, Japan.
  • Saji S; Japanese Foundation for Multidisciplinary Treatment of Cancer, 1-28-6 Kameido, Koto-ku, Tokyo, 136-0071, Japan.
  • Sakamoto J; Japanese Foundation for Multidisciplinary Treatment of Cancer, 1-28-6 Kameido, Koto-ku, Tokyo, 136-0071, Japan.
  • Tomita N; Division of Lower Gastrointestinal Surgery, Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, 663-8501, Japan. ntomita@hyo-med.ac.jp.
Int J Clin Oncol ; 22(4): 805-806, 2017 08.
Article em En | MEDLINE | ID: mdl-28608229

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article